Related Experiment Video
Updated: Aug 31, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in
Amit Bar-Or1, Robert K Nuttall, Martin Duddy
1Montreal Neurological Institute, Quebec, Canada.
Abstract:
Matrix metalloproteinases (MMPs) are implicated in multiple sclerosis where one of their roles may be to facilitate the transmigration of circulating leukocytes into the CNS. Studies have focused on only a few MMPs, and much remains unknown of which of the 23 MMP family members is/are critical to the multiple sclerosis disease process. Using quantitative real time polymerase chain reactions, we have systematically analysed the expression of all 23 MMP members in subsets of leukocytes isolated from the blood of normal individuals. We found a distinctive pattern of MMP expression in different cellular populations: MMP-11, MMP-26 and MMP-27 were enriched in B cells, while MMP-15, MMP-16, MMP-24 and MMP-28 were prominent in T lymphocytes. Of interest is the enrichment of a majority of MMP members in monocytes: MMP-1, MMP-3, MMP-9, MMP-10, MMP-14, MMP-19 and MMP-25. MMP-2 and MMP-17 were also significantly represented in monocytes, although B cells had significant amounts of these MMPs. In correspondence with their strong expression of many MMP members, monocytes migrated more rapidly across a model of the blood-brain barrier in culture than T or B lymphocytes. Finally, we found higher levels of two of the monocyte-expressed MMPs in multiple sclerosis patients compared with normal individuals: MMP-2 and MMP-14. Tissue inhibitor of metalloproteinases (TIMP)-2 was also elevated in monocytes from multiple sclerosis patients, providing a mechanism for the reported activation of MMP-2 by MMP-14 and TIMP-2. These results emphasize that monocytes are prominent contributors of the neuroinflammation in multiple sclerosis through a mechanism that involves their high MMP expression and that they identify specific MMP members as targets for novel therapeutics in the disease.
Insights
Matrix metalloproteinases (MMPs) are key in multiple sclerosis neuroinflammation. Monocytes express many MMPs, aiding blood-brain barrier crossing and identifying MMP-2 and MMP-14 as potential therapeutic targets.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in multiple sclerosis (MS) pathogenesis, potentially facilitating leukocyte infiltration into the central nervous system (CNS).
- Previous research has focused on a limited number of MMPs, leaving the roles of most of the 23 MMP family members in MS unclear.
Purpose of the Study:
- To systematically analyze the expression of all 23 MMP members in distinct leukocyte subsets from healthy individuals.
- To investigate the differential expression of MMPs in B cells, T lymphocytes, and monocytes.
- To identify specific MMPs that may be critical in the multiple sclerosis disease process.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) was used to analyze the expression of all 23 MMP family members.
- Leukocytes were isolated from the blood of normal individuals into distinct cellular populations (B cells, T lymphocytes, monocytes).
- Monocyte migration across a model of the blood-brain barrier was assessed in vitro.
Main Results:
- Distinct MMP expression patterns were observed across leukocyte subsets: MMP-11, MMP-26, MMP-27 in B cells; MMP-15, MMP-16, MMP-24, MMP-28 in T lymphocytes.
- Monocytes showed enrichment of a majority of MMP members, including MMP-1, MMP-3, MMP-9, MMP-10, MMP-14, MMP-19, MMP-25, MMP-2, and MMP-17.
- Monocytes exhibited more rapid migration across a blood-brain barrier model compared to T or B lymphocytes, correlating with their high MMP expression.
- Elevated levels of MMP-2 and MMP-14 were found in monocytes from multiple sclerosis patients compared to normal individuals.
- Tissue inhibitor of metalloproteinases (TIMP)-2 was also elevated in monocytes from multiple sclerosis patients.
Conclusions:
- Monocytes are significant contributors to neuroinflammation in multiple sclerosis due to their extensive MMP expression.
- The findings highlight specific MMPs, particularly MMP-2 and MMP-14, as potential therapeutic targets for multiple sclerosis.
- The elevated MMP-2 and TIMP-2 in monocytes suggests a mechanism involving MMP-14 and TIMP-2 in MMP-2 activation, contributing to disease pathology.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Inflammation
Chronic Inflammation: Introduction
Differentiation of Common Myeloid Progenitor Cells
